The latest news about biotechnologies, biomechanics
synthetic biology, genomics, biomediacl engineering...
Posted: Dec 06, 2013
Singapore scientists engineer human stem cells and move closer to mastering regenerative medicine
(Nanowerk News) In an important scientific breakthrough in regenerative medicine, researchers at A*STAR’s Genome Institute of Singapore (GIS) have successfully converted human embryonic stem cells (hESCs) cultured in the laboratory to a state that is closer to the cells found in the human blastocyst. This means that scientists are one step closer to cultivating stem cells for research and potential therapeutic purposes, as well as understanding the processes of early human development. These findings are published in the current issue of the prestigious science journal Cell Stem Cell ("Induction of a Human Pluripotent State with Distinct Regulatory Circuitry that Resembles Preimplantation Epiblast").
Pluripotent stem cells such as hESCs and induced pluripotent stem cells (iPSCs) have the remarkable ability to differentiate into various cell types of the adult body while proliferating continuously in culture. In the field of regenerative medicine, these cells are potentially a limitless resource to generate cells of different body parts such as the eye, liver, brain, kidney and pancreas to treat degenerative diseases or replace of worn out organs. Pluripotency is the essential property of the cells of the blastocyst in the early stages of human development. However, when cultured in the laboratory, these cells adopt molecular differences, which limit their use in therapeutic applications or disease modeling.
Using previously established hESCs, the researchers screened for culture conditions that could induce a stable change of cell state. They found that the use of a specific combination of small molecules and growth factors, termed 3iL, converted hESCs to a state that resembled cells within the native blastocysts.
The GIS team’s discovery will empower researchers with a novel resource to tackle existing challenges. “For the past 15 years, scientists could only work on a single hESC state. We now provide a novel cell state for all hESC applications,” said Prof Ng Huck Hui. “The results from the study will open many new possibilities to study human development and disease. The 3iL hESCs will help to overcome some of the obstacles that limit the potential of pluripotent cells in regenerative medicine.”
The researchers also found that many genes which are active in blastocyst cells but inactive in hESCs were turned on again in this novel cell state. These re-activated genes also showed epigenetic differences. “Every cell has a ’memory’, the epigenome, which is a layer on top of the genome that marks active and inactive genes,” explained Dr Jonathan Göke, a bioinformatician from GIS “When we looked into the epigenome of these 3iL cells, we found that this ‘memory’ was dramatically different; the cells appeared to be partly set back to the state of the embryo.”
To demonstrate how these 3iL hESCs can be used to obtain insights into human development, Prof Ng’s team studied the regulatory system that controls these developmental genes. “Studies of basic mechanisms like gene regulation require a large number of cells,” said Dr Chan Yun Shen, co-lead author, and researcher at GIS. “This is the first time that we are able to see how these genes are potentially regulated. While additional experiments will help to fully characterize these 3iL hESCs, we can already see that they provide an unprecedented way to study early human development without the use of any blastocysts.”
 The blastocyst is a structure formed in the early development of mammals. In humans, its formation begins five days after fertilization. It possesses an inner cell mass (ICM), or embryoblast, which subsequently forms the embryo, and an outer layer of cells, or trophoblast, surrounding the inner cell mass and a fluid-filled cavity known as the blastocoele. The human blastocyst comprises 70-100 cells.